Nasal extramedullary plasmacytoma

Authors

  • Hugo Rodrigues Interno do Internato Complementar de ORL do Hospital Garcia de Orta, Almada, Portugal
  • Inês Pinto da Silva Interna do Internato Complementar de ORL do Hospital Garcia de Orta, Almada, Portugal
  • Sara Tavares Interna do Internato Complementar de ORL do Hospital Garcia de Orta, Almada, Portugal
  • Carla André Assistente Hospitalar de ORL do Hospital Garcia de Orta, Almada, Portugal
  • Mário Santos Assistente Graduado de ORL do Hospital Garcia de Orta, Almada, Portugal
  • Brito Mendes Chefe de Serviço de ORL do Hospital Garcia de Orta, Almada, Portugal
  • Luís Antunes Diretor do Serviço de ORL do Hospital Garcia de Orta, Almada, Portugal

DOI:

https://doi.org/10.34631/sporl.141

Abstract

The myeloma tumors characterized by monoclonal proliferation typically producing immunoglobulin. They may present as a single lesion (solitary plasmacytoma) or multiple lesions (multiple myeloma). The lesions usually occur only in the bones (bone plasmacytoma) but may also occur in most soft tissue (extramedullary plasmacytoma). Their most frequent location is in the head and neck, the peak incidence is in 50-60 years of age, being twice as common in males. We describe the case of a woman, 56 years of age, with nasal complaints and mass of the left nasal cavity, initially interpreted as a nasal polyp. The patient underwent endoscopic sinus surgery with resection of the mass and the pathologic result revealed plasmacytoma. The subsequent investigation showed no evidence of systemic disease. Additionally, we reviewed the caseload for our service and identified two more cases to which we also refer.

References

Jaffe, ES, Harris, NL, Stein, H, Vardiman, JW (Eds). World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, IARC Press, Lyon 2001.

Soutar, R, Lucraft, H, Jackson, G, et al. Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Br J Haematol 2004; 124:717.

Dimopoulos, MA, Moulopoulos, LA, Maniatis, A, Alexanian, R. Solitary plasmacytoma of bone and asymptomatic multiple myeloma. Blood 2000; 96:2037.

Dores, GM, Landgren, O, McGlynn, KA, et al. Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992-2004. Br J Haematol 2009; 144:86.

Frassica, DA, Frassica, FJ, Schray, MF, et al. Solitary plasmacytoma of bone: Mayo Clinic experience. Int J Radiat Oncol Biol Phys 1989; 16:43.

Bataille, R, Sany, J. Solitary myeloma: clinical and prognostic features of a review of 114 cases. Cancer 1981; 48:845.

International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 2003; 121:749.

Rajkumar, SV, Dispenzieri, A, Kyle, RA. Monoclonal gammopathy of undetermined significance, Waldenström macroglobulinemia, AL amyloidosis, and related plasma cell disorders: diagnosis and treatment. Mayo Clin Proc 2006; 81:693.

Hughes, M, Doig, A, Soutar, R. Solitary plasmacytoma and multiple myeloma: adhesion molecule and chemokine receptor expression patterns. Br J Haematol 2007; 137:486.

Creach, KM, Foote, RL, Neben-Wittich, MA, Kyle, RA. Radiotherapy for extramedullary plasmacytoma of the head and neck. Int J Radiat Oncol Biol Phys 2009; 73:789.

Avilés, A, Huerta-Guzmán, J, Delgado, S, et al. Improved outcome in solitary bone plasmacytomata with combined therapy. Hematol Oncol 1996; 14:111.

Dimopoulos, MA, Goldstein, J, Fuller, L, et al. Curability of solitary bone plasmacytoma. J Clin Oncol 1992; 10:587.

How to Cite

Rodrigues, H., Pinto da Silva, I., Tavares, S., André, C., Santos, M., Mendes, B., & Antunes, L. (2012). Nasal extramedullary plasmacytoma. Portuguese Journal of Otorhinolaryngology and Head and Neck Surgery, 50(1), 85–88. https://doi.org/10.34631/sporl.141

Issue

Section

Case Report